Core Viewpoint - The article discusses the recent financing round of Ruisi Technology, highlighting its innovative approach to myopia prevention through AI and visual neural intervention, and the establishment of a comprehensive "product-data-service" closed-loop system [2][4]. Financing and Investment - Ruisi Technology recently completed a multi-million financing round led by Huaxi Jinzhi, with existing shareholder Innovation Works increasing their investment [2]. - The funds will be allocated for clinical registration, sales enhancement, brand building, and ongoing product R&D [2]. Technology and Product Development - The company focuses on addressing the core issues of myopia prevention in adolescents, leveraging advanced AI technology and clinical evidence [2]. - Ruisi Technology is developing a "light-eye-brain" intelligent treatment closed-loop system, integrating optical stimulation, neural regulation, and AI feedback [2][3]. - The product system is characterized by "strong technology + soft standards," with innovations in hardware and algorithmic layers [2]. Clinical Validation and Efficacy - Clinical studies involving reputable medical institutions show that Ruisi Technology's products significantly outperform traditional myopia prevention methods [3]. - In a real-world study of nearly 200 cases over six months, the experimental group showed an average axial length increase of only 0.038mm, compared to 0.125mm in the control group [3]. Market Position and Future Outlook - Ruisi Technology aims to integrate treatment into daily life, promoting a seamless experience of "learning while treating" and "playing while adjusting" [3]. - The company has established a network of hundreds of professional institutions and over 1,000 stores, laying the groundwork for a long-term prescription treatment model [3]. - The co-founder expressed confidence in the company's unique advantages in original technology, real-world validation, and industry standards, projecting over 100% revenue growth year-on-year for the first half of 2025 [4]. Industry Insights - The eye care sector is recognized as a vast and mature market, with significant potential for growth driven by technological advancements [5]. - Investors have noted Ruisi Technology's differentiated products supported by clinical data, which naturally integrate into learning and entertainment scenarios, creating high industry barriers [5]. - The company's innovative "Far Vision Light Screen" product has gained recognition among eye care professionals and users, enhancing personalized myopia management services [5].